by Piotr Witkowski | Sep 13, 2026 | Latest News
Stimulated by the extremely promising preliminary results from our pilot study involving 12 patients, Eledon Pharmaceuticals has submitted an IND application to the U.S. Food and Drug Administration (FDA). This represents the first and a very important step toward...
